The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,847,381 in first-year total cost, median $997,302.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-Q (F1)]8
- Special Emphasis Panel[ZHL1 CSR-Q (F2)]4
Most frequent institutions
- ARONORA, INC.2
- ADIENT MEDICAL, INC.1
- CORIDEA, LLC1
- CYTOSORBENTS, INC.1
- DNA MEDICINE INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Factor XI inhibitor for thrombosis2R44HL106919-05 | LORENTZ, CHRISTINA UTUCKER, ERIK IAN | ARONORA, INC., OR | $999,525 | ZHL1 |
| 2018 | CLOSURE DEVICE FOR TRANSCAVAL ACCESS TO THE ABDOMINAL AORTA2R44HL137001-04A1 | RAFIEE, NASSER | TRANSMURAL SYSTEMS, LLC, MA | $996,496 | ZHL1 |
| 2018 | pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads2R44HL141928-03 | CHAN, PHILLIP | CYTOSORBENTS, INC., NJ | $995,984 | ZHL1 |
| 2018 | Painless Defibrillation2R44HL127771-03 | LEVIN, HOWARD | CORIDEA, LLC, NY | $994,306 | ZHL1 |
| 2018 | Commercialization of an Ultrasound-guided Vascular Access Device2R44HL093879-05 | LIAPI, ELENI A.ZHANG, PEI | PERCEPTIVE NAVIGATION, LLC, MD | $932,293 | ZHL1 |
| 2017 | Clinical Evaluation of a Resorbable Vena Cava Filter2R44HL127734-03 | EGGERS, MITCHELL | ADIENT MEDICAL, INC., TX | $1,754,160 | ZHL1 |
| 2017 | Highly sensitive measurement of cTnI without a reader: the Xip solution2R44HL116078-03A1 | BHATIA, RAJINDER | SILICON BIODEVICES, INC., CA | $1,247,400 | ZHL1 |
| 2017 | Therapeutic Protein C Activator for Myocardial Ischemia2R44HL117589-04 | TUCKER, ERIK IANVERBOUT, NORAH | ARONORA, INC., OR | $998,107 | ZHL1 |
| 2017 | Improved long-term biocompatibility of coronary stents by plasma coating process2R44HL097485-04A1 | CHEN, MENG | NANOVA, INC., MO | $938,257 | ZHL1 |
| 2016 | STAT Palm-Sized Blood Counter2R44HL099092-04 | CHAN, EUGENE YAN-HOKELLOGG, MARK DAVID | DNA MEDICINE INSTITUTE, MA | $1,000,000 | ZHL1 |
| 2016 | Development and Preclinical Testing of the TORVAD Ventricular Assist System in Preparation for First in Human Implantation2R44HL117446-03 | GOHEAN, JEFFREY ROBERTLONGORIA, RAUL GSMALLING, RICHARD WARREN | WINDMILL CARDIOVASCULAR SYSTEMS, INC., TX | $999,377 | ZHL1 |
| 2016 | Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage2R44HL132172-03 | DUNHAM, ANDREWYOSHIDA, TATSURO | NEW HEALTH SCIENCES, INC., MA | $991,476 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.